Title |
A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
|
---|---|
Published in |
PLOS ONE, August 2011
|
DOI | 10.1371/journal.pone.0021225 |
Pubmed ID | |
Authors |
Gavin J. Churchyard, Cecilia Morgan, Elizabeth Adams, John Hural, Barney S. Graham, Zoe Moodie, Doug Grove, Glenda Gray, Linda-Gail Bekker, M. Juliana McElrath, Georgia D. Tomaras, Paul Goepfert, Spyros Kalams, Lindsey R. Baden, Michelle Lally, Raphael Dolin, William Blattner, Artur Kalichman, J. Peter Figueroa, Jean Pape, Mauro Schechter, Olivier Defawe, Stephen C. De Rosa, David C. Montefiori, Gary J. Nabel, Lawrence Corey, Michael C. Keefer, and the NIAID HIV Vaccine Trials Network |
Mendeley readers
The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
South Africa | 1 | <1% |
Unknown | 121 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 22 | 18% |
Researcher | 22 | 18% |
Student > Master | 22 | 18% |
Student > Bachelor | 11 | 9% |
Student > Doctoral Student | 9 | 7% |
Other | 16 | 13% |
Unknown | 21 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 24 | 20% |
Medicine and Dentistry | 21 | 17% |
Biochemistry, Genetics and Molecular Biology | 19 | 15% |
Immunology and Microbiology | 11 | 9% |
Social Sciences | 5 | 4% |
Other | 17 | 14% |
Unknown | 26 | 21% |